| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37f4922dfb7777b019e504b885211b8e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_43a72884e25aaecffebe0942132d704f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-70596
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-28 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5058
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5023 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| filingDate |
2010-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2018-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_baf0d2416f652cb77068eb1f3a85b27e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_714512c9b294396bd8f0820e17c84865
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_383819cf658984deeda859f837247ccf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b69283c9ed81be6416f92a47e1691251 |
| publicationDate |
2018-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2677564-T3 |
| titleOfInvention |
Pharmaceutical method and composition for use in the treatment of neurodegenerative disorders |
| abstract |
A compound that activates the BASIGIN signaling pathway for use in a method of treating a retinal neurodegenerative disorder, wherein said compound is a nucleic acid encoding BASIGINE. |
| priorityDate |
2009-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |